MBMarta BoffitoMD, PhD, FRCP, MBASlidesetSpanish HIV Clinical Forum 2016Pharmacological Considerations in Optimal Integrase Inhibitors Clinical Care - David BackView Slideset
JSJonathan SchapiroMDSlidesetSpanish HIV Clinical Forum 2016Resistance Characteristics of Integrase Inhibitors - Jonathan Schapiro, MDView Slideset
JAJose ArribasMDVideoHIVEuropean HIV Clinical Forum 2016Clinical Case Presentations - Experience with Induction-Maintenance Therapy in real life settings | José Arribas, MDView Video
PCPedro CahnMD, PhDVideoHIVEuropean HIV Clinical Forum 2016Induction-Maintenance ARV Therapy: Why, Who, When and How? | Pedro Cahn, MD, PhDView Video
SKSaye KhooMD, PhDVideoHIVEuropean HIV Clinical Forum 2016Clinical Utility of Integrase Inhibitors during pregnancy | Saye Khoo, MD, PhDView Video
AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVEuropean HIV Clinical Forum 2016Clinical Case Presentations – How to manage drug - drug interactions - the practice | Anna Maria Geretti, MD, PhD, FRCPathView Video
GDPGiovanni Di PerriMD, PhDVideoHIVEuropean HIV Clinical Forum 2016How to manage drug - drug interactions - the theory | Giovanni Di Perri, MD, PhDView Video
CFCourtney FletcherPharmDVideoHIVEuropean HIV Clinical Forum 2016Impact on: Pharmacology – penetration to sanctuary sites and drug-drug interactions | Courtney Fletcher, PharmDView Video
DKDaniel KuritzkesMDVideoHIVEuropean HIV Clinical Forum 2016Impact on: Virology/Resistance | Daniel Kuritzkes, MDView Video
VideoHIVEuropean HIV Clinical Forum 2016Impact on: Adherence/tolerability | Ian McGowan, MB, ChB, DPhil, MD, FRCPView Video
GDPGiovanni Di PerriMD, PhDSlidesetHIVEuropean HIV Clinical Forum 2016How to manage drug - drug interactions - the theory - Giovanni Di Perri, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2016Maintenance Therapy with Dolutegravir/Rilpivirin is efficient and well tolerated in a real-life setting - Katharina Grabmeijer PfistershammerView Slideset
